Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
about
Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.Vertebrate food products as a potential source of prion-like α-synuclein.The epigenetic component of the brain response to electromagnetic stimulation in Parkinson's Disease patients: A literature overview.Developing DNA methylation-based diagnostic biomarkers.Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?
P2860
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
@en
type
label
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
@en
prefLabel
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics.
@en
P2860
P921
P356
P1476
Epigenetic Biomarkers for Parkinson's Disease: From Diagnostics to Therapeutics
@en
P2093
Jennifer L Jakubowski
P2860
P356
10.3233/JPD-160914
P5008
P577
2017-01-01T00:00:00Z